4
Changes in Ownership
Korro Bio, Inc. Filed Acc 0000950170-24-125822
Chief Financial Officer sold 800 shares at $70.00 ($56,000)
- Chief Financial Officer acquired 800 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Agarwal Vineet · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-11 | Exercise or conversion : show line 1 in the form 10b5-1 | +800 | $11.68 | $9,344 | 800 | D |
| 2024-11-11 | Sale : show line 2 in the form 10b5-1 | −800 | $70.00 | $56,000 | 0 | D |
| Open-market sales · 800 sh · avg $70.00 · $56,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-11-11 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −800 | 30,807 | D |
Loading xslF345X05/ownership.xml…